Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,731 | -13,461 | -56,025 | -44,445 | -29,480 |
| Depreciation Amortization | -617 | -224 | 543 | 526 | 353 |
| Accounts payable and accrued liabilities | 1,835 | -90 | -401 | -474 | 501 |
| Other Working Capital | -6,851 | -6,385 | 3,824 | 3,741 | 2,383 |
| Other Operating Activity | 1,430 | 1,726 | 6,714 | 5,148 | 2,717 |
| Operating Cash Flow | $-34,935 | $-18,433 | $-45,345 | $-35,504 | $-23,527 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,500 | 9,000 | N/A | 0 | 0 |
| PPE Investments | -107 | -80 | -142 | -18 | -11 |
| Purchase Of Investment | -83,984 | -71,991 | -88,596 | 0 | 0 |
| Investing Cash Flow | $-52,591 | $-63,071 | $-88,738 | $-18 | $-11 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 205 | 181 | 230,309 | 230,080 | 13,813 |
| Other Financing Activity | 0 | 0 | -3,726 | -3,139 | -64 |
| Financing Cash Flow | $205 | $181 | $226,583 | $226,941 | $13,749 |
| Beginning Cash Position | 128,645 | 128,645 | 36,145 | 36,145 | 36,145 |
| End Cash Position | 41,325 | 47,322 | 128,645 | 227,563 | 26,356 |
| Net Cash Flow | $-87,320 | $-81,324 | $92,500 | $191,418 | $-9,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,935 | -18,433 | -45,345 | -35,504 | -23,527 |
| Capital Expenditure | -107 | -80 | -142 | -18 | -11 |
| Free Cash Flow | -35,042 | -18,513 | -45,487 | -35,522 | -23,538 |